Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Pulmonology (Drugs, Pharmaceuticals, Biotechnology & Biosimilars)
Avalyn Pharma, formerly, Genoa Pharmaceuticals (ALVN)

Organization & Developments: Avalyn Pharma

Parents

*Advancing drug candidate treatments for pulmonary fibrosis conditions.
*Biopharmaceuticals for treatment of idiopathic pulmonary fibrosis and severe respiratory diseases.
*Developing inhaled formulations of already-approved drugs of pirfenidone and nintedanib for treating progressive pulmonary fibrosis and idiopathic pulmonary fibrosis.
*Developing targeted treatment candidates for interstitial lung diseases [ILDs] like pulmonary fibrosis
*Inhaled formulation of pirfenidone to increase the amount of drug entering the lungs for treatment of rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs)